Literature DB >> 1508605

A mutation in the E1 alpha subunit of pyruvate dehydrogenase associated with variable expression of pyruvate dehydrogenase complex deficiency.

I D Wexler1, S G Hemalatha, T C Liu, S A Berry, D S Kerr, M S Patel.   

Abstract

Defects in pyruvate dehydrogenase, the first catalytic component of the pyruvate dehydrogenase complex, are the most common cause of pyruvate dehydrogenase complex deficiency. A family with variable pyruvate dehydrogenase complex deficiency had been described in which cultured skin fibroblasts of affected family members had normal pyruvate dehydrogenase complex activity, but different tissues and blood lymphocytes had significantly diminished activities. Enzymatic activity and immunoblot studies indicated that pyruvate dehydrogenase was affected. Further evidence is presented here showing that the defect affecting pyruvate dehydrogenase complex activity is posttranscriptional. Sequencing of the coding region of the alpha-subunit of pyruvate dehydrogenase revealed a point mutation in the codon for amino acid 234 resulting in a substitution of glycine for arginine. Study of other members of the family suggested that this mutation is inherited in a sex-linked mode. The point mutation is located in a highly conserved region of the pyruvate dehydrogenase alpha-subunit gene that contains both hydrophobic and positively charged amino acid residues. Variable expression of pyruvate dehydrogenase complex deficiency in this case may be due to instability of the pyruvate dehydrogenase heterotetramer in specific tissues because of a disruption in subunit-subunit interaction.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1508605     DOI: 10.1203/00006450-199208000-00009

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  7 in total

1.  Enzymatic testing sensitivity, variability and practical diagnostic algorithm for pyruvate dehydrogenase complex (PDC) deficiency.

Authors:  Ha Kyung Shin; George Grahame; Shawn E McCandless; Douglas S Kerr; Jirair K Bedoyan
Journal:  Mol Genet Metab       Date:  2017-09-08       Impact factor: 4.797

Review 2.  Pyruvate dehydrogenase E1 alpha deficiency: males and females differ yet again.

Authors:  H H Dahl
Journal:  Am J Hum Genet       Date:  1995-03       Impact factor: 11.025

3.  Biochemical and molecular analysis of an X-linked case of Leigh syndrome associated with thiamin-responsive pyruvate dehydrogenase deficiency.

Authors:  E Naito; M Ito; I Yokota; T Saijo; J Matsuda; H Osaka; S Kimura; Y Kuroda
Journal:  J Inherit Metab Dis       Date:  1997-08       Impact factor: 4.982

4.  Characterization of a point mutation in the pyruvate dehydrogenase E1 alpha gene from two boys with primary lactic acidaemia.

Authors:  H Awata; F Endo; A Tanoue; A Kitano; I Matsuda
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

5.  A cognitively normal PDH-deficient 18-year-old man carrying the R263G mutation in the PDHA1 gene.

Authors:  R Bachmann-Gagescu; J Lawrence Merritt; S H Hahn
Journal:  J Inherit Metab Dis       Date:  2009-07-29       Impact factor: 4.982

6.  Mutations in the X-linked E1 alpha subunit of pyruvate dehydrogenase: exon skipping, insertion of duplicate sequence, and missense mutations leading to the deficiency of the pyruvate dehydrogenase complex.

Authors:  K Chun; N MacKay; R Petrova-Benedict; A Federico; A Fois; D E Cole; E Robertson; B H Robinson
Journal:  Am J Hum Genet       Date:  1995-03       Impact factor: 11.025

7.  Clinical manifestations in two patients with pyruvate dehydrogenase deficiency and long-term survival.

Authors:  Takanobu Yoshida; Jun Kido; Hiroshi Mitsubuchi; Shirou Matsumoto; Fumio Endo; Kimitoshi Nakamura
Journal:  Hum Genome Var       Date:  2017-06-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.